Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis (NCT02968810)

🧪 Interventions in This Study

• Simvastatin (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (5 Sites)

• Cedars-Sinai Medical Center — Los Angeles, California
• MedStar Georgetown University Hospital — Washington D.C., District of Columbia
• Northwestern University — Chicago, Illinois
• Centro Comprensivo de Cancer de UPR — San Juan,
• University of Puerto Rico — San Juan,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cirrhosis

• Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement — Richmond, Virginia
• Liver Cirrhosis Network Cohort Study — La Jolla, California
• Oral Health In Cirrhosis of the Liver (ORACLE) — Richmond, Virginia
• Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis — Ann Arbor, Michigan
• Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis — San Francisco, California

Explore by condition: All Cirrhosis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.